Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
4.690
+0.120 (2.63%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Aligos Therapeutics Employees
Aligos Therapeutics had 70 employees as of December 31, 2024. The number of employees increased by 4 or 6.06% compared to the previous year.
Employees
70
Change (1Y)
4
Growth (1Y)
6.06%
Revenue / Employee
$56,357
Profits / Employee
-$1,874,443
Market Cap
28.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
ALGS News
- 24 days ago - Aligos Therapeutics Presents Positive Data at APASL 2025 - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025 - GlobeNewsWire
- 2 months ago - Aligos Therapeutics Announces $105 Million Private Placement Financing - GlobeNewsWire
- 5 months ago - Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024 - GlobeNewsWire
- 5 months ago - Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - Aligos Therapeutics Appoints David Perry as Vice President of Business Development - GlobeNewsWire